After a nurse died after just two weight-loss injections of Mounjaro - which is approved for use on the NHS - here's ...
With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...
The Healthy on MSN1d
New Data: Nearly 50% of Weight-Loss Drug Patients Saw Lower Consumption of This, Too"For healthcare providers, these findings suggest that anti-obesity medications may offer dual benefits," one doctor reports ...
For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...
Once-weekly semaglutide shows significant reduction in knee osteoarthritis pain and body weight in adults with obesity, a ...
Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths ...
Novo Nordisk President and CEO Lars Fruergaard Jorgensen, shown testifying on Capitol Hill in September, is warning about potential risks from compounded versions of the drug semaglutide.
It’s certainly better than nothing, but you are right that semaglutide (Ozempic when prescribed for diagnosed diabetes and Wegovy when prescribed for weight loss) will be more effective.
About The Study: Among patients with alcohol use disorder (AUD) and comorbid obesity/type 2 diabetes, the use of semaglutide and liraglutide were associated with a substantially decreased risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback